CASP6 and Huntington disease: Supporting the latter hypothesis, mutation of obligate aspartate residues in the caspase recognition regions of HTT has established that cleavage at amino acid 586, a caspase-6 site in vitro, is crucial for the development of HD symptoms in a mouse model [18-20].